A coxibok hatásai és mellékhatásai

Translated title of the contribution: A reumatológiai gyakorlatban

Research output: Contribution to journalArticle

Abstract

The author reviews the various tools of pain control in rheumatic disorders, with special attention to the pharmacological modalities, focusing on the use of cyclo-oxygenase inhibitors (coxibs). The new pain control drugs have different side-effect profiles, and even though these are more favourable than those of the traditional drugs, not all of them meet the strict safety requirements. The new drugs that are available in Hungary have a lower gastrointestinal side effect risk than the traditional nonsteroidal anti-inflammatory drugs, still with comparable effectiveness. The non-steroidal antiinflammatory drugs - including the selective cyclo-oxygenase inhibitors - increase the risk of cardiovascular disease, though to varying extent. When choosing a drug to control pain and inflammation in the diseases of the locomotor system, the physician should balance between the effectiveness and the most common side effects (gastrointestinal, cardiovascular).

Original languageHungarian
Pages (from-to)469-475
Number of pages7
JournalLege Artis Medicinae
Volume18
Issue number6-7
Publication statusPublished - Jul 2008

Fingerprint

Cyclooxygenase Inhibitors
Drug and Narcotic Control
Pain
Pharmaceutical Preparations
Anti-Inflammatory Agents
Hungary
Cardiovascular Diseases
Pharmacology
Inflammation
Physicians
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A coxibok hatásai és mellékhatásai. / Géher, P.

In: Lege Artis Medicinae, Vol. 18, No. 6-7, 07.2008, p. 469-475.

Research output: Contribution to journalArticle

Géher, P. / A coxibok hatásai és mellékhatásai. In: Lege Artis Medicinae. 2008 ; Vol. 18, No. 6-7. pp. 469-475.
@article{928b9298bfb04f15b7b94618dc18be2a,
title = "A coxibok hat{\'a}sai {\'e}s mell{\'e}khat{\'a}sai",
abstract = "The author reviews the various tools of pain control in rheumatic disorders, with special attention to the pharmacological modalities, focusing on the use of cyclo-oxygenase inhibitors (coxibs). The new pain control drugs have different side-effect profiles, and even though these are more favourable than those of the traditional drugs, not all of them meet the strict safety requirements. The new drugs that are available in Hungary have a lower gastrointestinal side effect risk than the traditional nonsteroidal anti-inflammatory drugs, still with comparable effectiveness. The non-steroidal antiinflammatory drugs - including the selective cyclo-oxygenase inhibitors - increase the risk of cardiovascular disease, though to varying extent. When choosing a drug to control pain and inflammation in the diseases of the locomotor system, the physician should balance between the effectiveness and the most common side effects (gastrointestinal, cardiovascular).",
keywords = "Coxib, Pain control, Rheumatology, Side-effects",
author = "P. G{\'e}her",
year = "2008",
month = "7",
language = "Hungarian",
volume = "18",
pages = "469--475",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "6-7",

}

TY - JOUR

T1 - A coxibok hatásai és mellékhatásai

AU - Géher, P.

PY - 2008/7

Y1 - 2008/7

N2 - The author reviews the various tools of pain control in rheumatic disorders, with special attention to the pharmacological modalities, focusing on the use of cyclo-oxygenase inhibitors (coxibs). The new pain control drugs have different side-effect profiles, and even though these are more favourable than those of the traditional drugs, not all of them meet the strict safety requirements. The new drugs that are available in Hungary have a lower gastrointestinal side effect risk than the traditional nonsteroidal anti-inflammatory drugs, still with comparable effectiveness. The non-steroidal antiinflammatory drugs - including the selective cyclo-oxygenase inhibitors - increase the risk of cardiovascular disease, though to varying extent. When choosing a drug to control pain and inflammation in the diseases of the locomotor system, the physician should balance between the effectiveness and the most common side effects (gastrointestinal, cardiovascular).

AB - The author reviews the various tools of pain control in rheumatic disorders, with special attention to the pharmacological modalities, focusing on the use of cyclo-oxygenase inhibitors (coxibs). The new pain control drugs have different side-effect profiles, and even though these are more favourable than those of the traditional drugs, not all of them meet the strict safety requirements. The new drugs that are available in Hungary have a lower gastrointestinal side effect risk than the traditional nonsteroidal anti-inflammatory drugs, still with comparable effectiveness. The non-steroidal antiinflammatory drugs - including the selective cyclo-oxygenase inhibitors - increase the risk of cardiovascular disease, though to varying extent. When choosing a drug to control pain and inflammation in the diseases of the locomotor system, the physician should balance between the effectiveness and the most common side effects (gastrointestinal, cardiovascular).

KW - Coxib

KW - Pain control

KW - Rheumatology

KW - Side-effects

UR - http://www.scopus.com/inward/record.url?scp=61849154840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849154840&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:61849154840

VL - 18

SP - 469

EP - 475

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 6-7

ER -